A retrospective analysis of extended-interval dosing and the impact on bisphosphonate compliance in the US Military Health System

被引:0
|
作者
J. Devine
S. Trice
Z. Finney
S. Yarger
E. Nwokeji
A. Linton
W. Davies
机构
[1] TRICARE Management Activity (TMA),
[2] Pharmacoeconomic Center,undefined
[3] TRICARE Management Activity (TMA),undefined
[4] Pharmacy Operations Directorate,undefined
来源
关键词
Adherence; Bisphosphonate; Compliance; Osteoporosis; Persistence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1415 / 1424
页数:9
相关论文
共 44 条
  • [31] Impact of Infliximab Dosing Regimen during Pregnancy in Pregnant Women with Chronic Inflammatory Bowel Disease: A Descriptive Analysis of the National Health Data System Database
    Cholle, C.
    Benzenine, E.
    Combret, S.
    Barkun, A.
    Doret, M.
    Michiels, C.
    Quantin, C.
    Bardou, M.
    Luu, M.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 57 - 58
  • [32] A RETROSPECTIVE US CLAIMS DATABASE ANALYSIS OF THE IMPACT OF FREMANEZUMAB ON MIGRAINE-RELATED HEALTH CARE UTILIZATION AND COSTS IN PATIENTS WITH POTENTIAL ACUTE MEDICATION OVERUSE
    Buse, D. C.
    Driessen, M. T.
    Krasenbaum, L. J.
    Seminerio, M. J.
    Carr, K.
    Ortega, M.
    Packnett, E.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S338 - S338
  • [33] IMPACT OF MEDICATION THERAPY MANAGEMENT (MTM) SERVICES ON HEALTH CARE COSTS IN POLYPHARMACY PATIENTS: EVIDENCE FROM RETROSPECTIVE CLAIMS ANALYSIS OF COMMERCIALLY INSURED US POPULATION
    Soliman, A. M.
    Carlson, A.
    Dowd, B.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A206 - A206
  • [34] Digoxin and Standard-of-Care Therapy for Heart Failure Patients with COVID-19: Analysis of Data from the US Military Health System (MHS) Data Repository
    Amanda L. Banaag
    Harvey B. Pollard
    Tracey P. Koehlmoos
    [J]. Drugs - Real World Outcomes, 2023, 10 : 299 - 307
  • [35] Digoxin and Standard-of-Care Therapy for Heart Failure Patients with COVID-19: Analysis of Data from the US Military Health System (MHS) Data Repository
    Banaag, Amanda L.
    Pollard, Harvey B.
    Koehlmoos, Tracey P.
    [J]. DRUGS-REAL WORLD OUTCOMES, 2023, 10 (02) : 299 - 307
  • [36] Impact of home-based, patient-centered support for people with advanced illness in an open health system: A retrospective claims analysis of health expenditures, utilization, and quality of care at end of life
    Sudat, Sylvia E. K.
    Franco, Anjali
    Pressman, Alice R.
    Rosenfeld, Kenneth
    Gornet, Elizabeth
    Stewart, Walter
    [J]. PALLIATIVE MEDICINE, 2018, 32 (02) : 485 - 492
  • [37] Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective
    Lorenzoni, Valentina
    Triulzi, Isotta
    Turchetti, Giuseppe
    [J]. BMC HEALTH SERVICES RESEARCH, 2018, 18
  • [38] Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective
    Valentina Lorenzoni
    Isotta Triulzi
    Giuseppe Turchetti
    [J]. BMC Health Services Research, 18
  • [39] BUDGET IMPACT ANALYSIS OF THE USE OF EXTENDED HALF-LIFE RECOMBINANT FACTOR VIII (EFMOROCTOG ALFA) FOR THE TREATMENT OF CONGENITAL HAEMOPHILIA A: THE ITALIAN NATIONAL HEALTH SYSTEM PERSPECTIVE
    Lorenzoni, V
    Triulzi, I
    Turchetti, G.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A580 - A580
  • [40] A REAL-WORLD US RETROSPECTIVE DATABASE ANALYSIS EVALUATING TREATMENT PATTERNS, HEALTH CARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH BIPOLAR DISORDER NEWLY TREATED WITH IMMEDIATE RELEASE (IR) OR EXTENDED RELEASE (XR) QUETIAPINE FUMARATE
    Locklear, J. C.
    Alemayehu, B.
    Brody, R. S.
    Chavoshi, S.
    Tunceli, O.
    Kern, D.
    Earley, W. R.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A83 - A83